Needle-Free Drug Delivery Devices Market Projected for Strong Growth
The markets for needle-free injection systems and microneedle devices are expected to grow significantly, with projections of nearly 15% and 20% annualized growth respectively, according to Roots Analysis. This growth is attributed to increasing demand for patient-friendly and effective drug delivery solutions.
The global market for needle-free drug delivery devices is poised for substantial expansion, driven by advancements in injection system and microneedle technologies, according to a report by Roots Analysis. The market for needle-free injection systems is projected to grow at an annualized rate of nearly 15%, while the microneedle device market is expected to see even faster growth at approximately 20% per year.
This growth trajectory is fueled by a rising preference for self-administration of therapies and the need for safer, more efficient drug delivery methods. Needle-free systems offer a pain-free experience and enable the delivery of medications that are challenging to administer via conventional needles. Factors such as reduced needlestick injuries and improved patient compliance are key drivers.
The report indicates a robust pipeline with nearly 60 needle-free injection systems and around 50 microneedle devices either available or under development. Many of these systems utilize spring or gas-powered actuators, while microneedles often employ dissolving or hollow designs. Furthermore, a significant number of biologics and small molecule drugs are being evaluated for compatibility with these advanced delivery platforms.
Geographically, North America and Europe are anticipated to hold the largest market share by 2030. However, the Asia-Pacific region is expected to exhibit the highest growth rate. Chronic diseases and infectious diseases are identified as the primary application areas, accounting for a substantial portion of the market due to the minimally invasive nature of these technologies.